Header cover image
  • Investing Ideas
  • /
  • South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

2

0 new

High return on equity, past performance and sound balance sheet.

2 companies

AprilBioLtd

Market Cap: ₩487.7b

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

A397030

₩21,150.00

7D

-6.0%

1Y

17.5%

JW Lifescience

Market Cap: ₩193.4b

Provides national infusion solutions in South Korea and internationally.

A234080

₩12,470.00

7D

-2.0%

1Y

4.8%